Hospitals

The primary goal is to elevate the standard of healthcare in Nigeria by enhancing both clinical and administrative practices within Iwosan’s growing network of hospitals.

The Burjeel Breast Center is designed as a one-stop destination, integrating advanced diagnostics, personalized treatment, and holistic support services under a single roof.

The primary goal is to provide a holistic, human-centered experience that addresses the physical, emotional, and psychological needs of cancer patients throughout their health journey.

Under the agreement, the initiative will focus on four main pillars. First, it will develop state-of-the-art laboratory infrastructure in Masdar City, equipped with the latest technologies to support advanced scientific research.

M42 and Juvenescence will work together to identify and develop a pipeline of AI-enabled therapeutics to extend healthy human lifespan and improve treatments for life-threatening and chronic diseases.

Unlike traditional open-chest surgeries, which typically require a large incision and significant recovery time, this modern technique uses advanced, minimally invasive methods.

This agreement aligns with DoH’s vision to create an intelligent healthcare system powered by genomic science, AI insights, and innovation across critical areas such as oncology, rare genetic diseases, and metabolic disorders.

The ROSA® system is a state-of-the-art robotic surgical assistant that works closely with surgeons from the planning stages right through to the operation itself.

The new facility, to be constructed at Cleveland Clinic Abu Dhabi, part of the M42 group, will bring one of the most advanced and effective cancer treatment technologies to the region.